{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:55:33Z","timestamp":1794851733554,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,22]]},"DOI":"10.7759\/cureus.24378","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T16:42:15Z","timestamp":1650645735000},"source":"Crossref","is-referenced-by-count":12,"title":["Hyperthyroidism and the Risk of Cardiac Arrhythmias: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Mahlika","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjana","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zineb","family":"Barkhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalal","family":"Elmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Satish Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Sree","family":"Pugalenthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell JG","year":"2002","unstructured":"Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002, 87:489-99. 10.1210\/jcem.87.2.8182","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2409","article-title":"The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis","volume":"99","author":"Garmendia Madariaga A","year":"2014","unstructured":"Garmendia Madariaga A, Santos Palacios S, Guill\u00e9n-Grima F, Galofr\u00e9 JC. The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab. 2014, 99:923-31. 10.1210\/jc.2013-2409","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1709318","article-title":"Subclinical hyperthyroidism","volume":"378","author":"Biondi B","year":"2018","unstructured":"Biondi B, Cooper DS. Subclinical hyperthyroidism. N Engl J Med. 2018, 378:2411-9. 10.1056\/NEJMcp1709318","journal-title":"N Engl J Med"},{"key":"ref5","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"72","author":"Reid JR","year":"2005","unstructured":"Reid JR, Wheeler SF. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2005, 72:623-30.","journal-title":"Am Fam Physician"},{"key":"ref6","article-title":"Hyperthyroidism in adults: variable clinical presentations and approaches to diagnosis","volume":"8","author":"Knudson PB","year":"1995","unstructured":"Knudson PB. Hyperthyroidism in adults: variable clinical presentations and approaches to diagnosis. J Am Board Fam Pract. 1995, 8:109-13.","journal-title":"J Am Board Fam Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12816","article-title":"Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters","volume":"84","author":"Goichot B","year":"2016","unstructured":"Goichot B, Caron P, Landron F, Bou\u00e9e S. Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters. Clin Endocrinol (Oxf). 2016, 84:445-51. 10.1111\/cen.12816","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00059-014-4123-0","article-title":"Arrhythmia and thyroid dysfunction","volume":"40 Suppl 2","author":"Marrakchi S","year":"2015","unstructured":"Marrakchi S, Kanoun F, Idriss S, Kammoun I, Kachboura S. Arrhythmia and thyroid dysfunction. Herz. 2015, 40 Suppl 2:101-9. 10.1007\/s00059-014-4123-0","journal-title":"Herz"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein I","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001, 344:501-9. 10.1056\/NEJM200102153440707","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-6-2-3","article-title":"The cardiovascular effects of hyperthyroidism","volume":"6","author":"Nabbout LA","year":"2010","unstructured":"Nabbout LA, Robbins RJ. The cardiovascular effects of hyperthyroidism. Methodist Debakey Cardiovasc J. 2010, 6:3-8. 10.14797\/mdcj-6-2-3","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.678326","article-title":"Thyroid disease and the heart","volume":"116","author":"Klein I","year":"2007","unstructured":"Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007, 116:1725-35. 10.1161\/CIRCULATIONAHA.106.678326","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.3.8603588","article-title":"Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart","volume":"137","author":"Ojamaa K","year":"1996","unstructured":"Ojamaa K, Klemperer JD, MacGilvray SS, Klein I. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology. 1996, 137:802-8. 10.1210\/endo.137.3.8603588","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.04.019","article-title":"Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium","volume":"475","author":"Kasturi S","year":"2008","unstructured":"Kasturi S, Ismail-Beigi F. Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium. Arch Biochem Biophys. 2008, 475:121-7. 10.1016\/j.abb.2008.04.019","journal-title":"Arch Biochem Biophys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(89)90142-2","article-title":"Cardiac arrhythmias and heart rate in hyperthyroidism","volume":"15","author":"von Olshausen K","year":"1989","unstructured":"von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, Meyer J. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol. 1989, 15:930-3. 10.1016\/0002-9149(89)90142-2","journal-title":"Am J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arteri.2014.07.003","article-title":"Effects of thyroid hormones on the heart","volume":"26","author":"Vargas-Uricoechea H","year":"2014","unstructured":"Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014, 26:296-309. 10.1016\/j.arteri.2014.07.003","journal-title":"Clin Investig Arterioscler"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.14797\/mdcj-13-2-60","article-title":"Hyperthyroidism and the heart","volume":"13","author":"Osuna PM","year":"2017","unstructured":"Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist Debakey Cardiovasc J. 2017, 13:60-3. 10.14797\/mdcj-13-2-60","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00000539-199710000-00005","article-title":"The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries","volume":"85","author":"Park KW","year":"1997","unstructured":"Park KW, Dai HB, Ojamaa K, Lowenstein E, Klein I, Sellke FW. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg. 1997, 85:734-8. 10.1097\/00000539-199710000-00005","journal-title":"Anesth Analg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2013.38685","article-title":"Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology","volume":"9","author":"Ertek S","year":"2013","unstructured":"Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci. 2013, 9:944-52. 10.5114\/aoms.2013.38685","journal-title":"Arch Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(70)90318-2","article-title":"Hyperthyroidism as a high cardiac output state","volume":"79","author":"DeGroot WJ","year":"1970","unstructured":"DeGroot WJ, Leonard JJ. Hyperthyroidism as a high cardiac output state. Am Heart J. 1970, 79:265-75. 10.1016\/0002-8703(70)90318-2","journal-title":"Am Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.20.2219","article-title":"High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study","volume":"168","author":"Heeringa J","year":"2008","unstructured":"Heeringa J, Hoogendoorn EH, van der Deure WM, et al.. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med. 2008, 168:2219-24. 10.1001\/archinte.168.20.2219","journal-title":"Arch Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.15.1675","article-title":"Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study","volume":"164","author":"Frost L","year":"2004","unstructured":"Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004, 164:1675-8. 10.1001\/archinte.164.15.1675","journal-title":"Arch Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411103311901","article-title":"Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons","volume":"331","author":"Sawin CT","year":"1994","unstructured":"Sawin CT, Geller A, Wolf PA, et al.. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994, 331:1249-52. 10.1056\/NEJM199411103311901","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000174467","article-title":"Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease","volume":"76","author":"Iwasaki T","year":"1989","unstructured":"Iwasaki T, Naka M, Hiramatsu K, et al.. Echocardiographic studies on the relationship between atrial fibrillation and atrial enlargement in patients with hyperthyroidism of Graves' disease. Cardiology. 1989, 76:10-7. 10.1159\/000174467","journal-title":"Cardiology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6088.688","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"2","author":"Staffurth JS","year":"1977","unstructured":"Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977, 2:688-90. 10.1136\/bmj.2.6088.688","journal-title":"Br Med J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.119370","article-title":"Subclinical hyperthyroidism as a risk factor for atrial fibrillation","volume":"142","author":"Auer J","year":"2001","unstructured":"Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001, 142:838-42. 10.1067\/mhj.2001.119370","journal-title":"Am Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7326\/AITC201703070","article-title":"Atrial fibrillation","volume":"166","author":"Zimetbaum P","year":"2017","unstructured":"Zimetbaum P. Atrial fibrillation. Ann Intern Med. 2017, 166:ITC33-48. 10.7326\/AITC201703070","journal-title":"Ann Intern Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"10. Nattel","year":"2002","unstructured":"10. Nattel, Stanley. New ideas about atrial fibrillation 50 years on. Nature. 2002, 415:219-26. 10.1038\/415219a","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46315","article-title":"Recent advances in the molecular pathophysiology of atrial fibrillation","volume":"121","author":"Wakili R","year":"2011","unstructured":"Wakili R, Voigt N, K\u00e4\u00e4b S, Dobrev D, Nattel S. Recent advances in the molecular pathophysiology of atrial fibrillation. J Clin Invest. 2011, 121:2955-68. 10.1172\/JCI46315","journal-title":"J Clin Invest"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.103.5.769","article-title":"Pathophysiology and prevention of atrial fibrillation","volume":"103","author":"Allessie MA","year":"2001","unstructured":"Allessie MA, Boyden PA, Camm AJ, et al.. Pathophysiology and prevention of atrial fibrillation. Circulation. 2001, 103:769-77. 10.1161\/01.cir.103.5.769","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00031.2009","article-title":"Pathophysiological mechanisms of atrial fibrillation: a translational appraisal","volume":"91","author":"Schotten U","year":"2011","unstructured":"Schotten U, Verheule S, Kirchhof P, Goette A. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011, 91:265-325. 10.1152\/physrev.00031.2009","journal-title":"Physiol Rev"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00828.2004","article-title":"Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria","volume":"289","author":"Hu Y","year":"2005","unstructured":"Hu Y, Jones SV, Dillmann WH. Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. Am J Physiol Heart Circ Physiol. 2005, 289:H1448-55. 10.1152\/ajpheart.00828.2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-291x(03)01420-7","article-title":"Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium","volume":"308","author":"Watanabe H","year":"2003","unstructured":"Watanabe H, Ma M, Washizuka T, et al.. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun. 2003, 308:439-44. 10.1016\/s0006-291x(03)01420-7","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(01)01731-4","article-title":"Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes","volume":"39","author":"Chen YC","year":"2002","unstructured":"Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002, 39:366-72. 10.1016\/s0735-1097(01)01731-4","journal-title":"J Am Coll Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0092","article-title":"Activation of electrical triggers of atrial fibrillation in hyperthyroidism","volume":"93","author":"Wustmann K","year":"2008","unstructured":"Wustmann K, Kucera JP, Zanchi A, et al.. Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab. 2008, 93:2104-8. 10.1210\/jc.2008-0092","journal-title":"J Clin Endocrinol Metab"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1172\/JCI113961","article-title":"Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis","volume":"83","author":"Liggett SB","year":"1989","unstructured":"Liggett SB, Shah SD, Cryer PE. Increased fat and skeletal muscle beta-adrenergic receptors but unaltered metabolic and hemodynamic sensitivity to epinephrine in vivo in experimental human thyrotoxicosis. J Clin Invest. 1989, 83:803-9. 10.1172\/JCI113961","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-44-6-1185","article-title":"Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism","volume":"44","author":"Coulombe P","year":"1977","unstructured":"Coulombe P, Dussault JH, Walker P. Catecholamine metabolism in thyroid disease. II. Norepinephrine secretion rate in hyperthyroidism and hypothyroidism. J Clin Endocrinol Metab. 1977, 44:1185-9. 10.1210\/jcem-44-6-1185","journal-title":"J Clin Endocrinol Metab"},{"key":"ref37","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1972.00320030050004","article-title":"Effect of atropine on the tachycardia of hyperthyroidism","volume":"129","author":"Heimbach DM","year":"1972","unstructured":"Heimbach DM, Crout JR. Effect of atropine on the tachycardia of hyperthyroidism. Arch Intern Med. 1972, 129:430-2.","journal-title":"Arch Intern Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2006.02514.x","article-title":"Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability","volume":"64","author":"Chen JL","year":"2006","unstructured":"Chen JL, Chiu HW, Tseng YJ, Chu WC. Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: evidence from spectral analysis of heart rate variability. Clin Endocrinol (Oxf). 2006, 64:611-6. 10.1111\/j.1365-2265.2006.02514.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-53491-0.00031-6","article-title":"Heart rate variability","volume":"117","author":"Cygankiewicz I","year":"2013","unstructured":"Cygankiewicz I, Zareba W. Heart rate variability. Handb Clin Neurol. 2013, 117:379-93. 10.1016\/B978-0-444-53491-0.00031-6","journal-title":"Handb Clin Neurol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.49.175","article-title":"Is 5-minute heart rate variability a useful measure for monitoring the autonomic nervous system of workers?","volume":"49","author":"Min KB","year":"2008","unstructured":"Min KB, Min JY, Paek D, Cho SI, Son M. Is 5-minute heart rate variability a useful measure for monitoring the autonomic nervous system of workers?. Int Heart J. 2008, 49:175-81. 10.1536\/ihj.49.175","journal-title":"Int Heart J"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.13-198","article-title":"Time-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunction","volume":"55","author":"Falcone C","year":"2014","unstructured":"Falcone C, Matrone B, Bozzini S, et al.. Time-domain heart rate variability in coronary artery disease patients affected by thyroid dysfunction. Int Heart J. 2014, 55:33-8. 10.1536\/ihj.13-198","journal-title":"Int Heart J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.281.1.E190","article-title":"Sympathovagal imbalance in hyperthyroidism","volume":"281","author":"Burggraaf J","year":"2001","unstructured":"Burggraaf J, Tulen JH, Lalezari S, et al.. Sympathovagal imbalance in hyperthyroidism. Am J Physiol Endocrinol Metab. 2001, 281:E190-5. 10.1152\/ajpendo.2001.281.1.E190","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.75.1.1619016","article-title":"Sinus node function in hyperthyroid patients","volume":"75","author":"Valcavi R","year":"1992","unstructured":"Valcavi R, Menozzi C, Roti E, et al.. Sinus node function in hyperthyroid patients. J Clin Endocrinol Metab. 1992, 75:239-42. 10.1210\/jcem.75.1.1619016","journal-title":"J Clin Endocrinol Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450691","article-title":"Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism","volume":"145","author":"Petretta M","year":"2001","unstructured":"Petretta M, Bonaduce D, Spinelli L, et al.. Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol. 2001, 145:691-6. 10.1530\/eje.0.1450691","journal-title":"Eur J Endocrinol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_61_18","article-title":"Alterations of heart rate variability and turbulence in female patients with hyperthyroidism of various severities","volume":"22","author":"Tudoran C","year":"2019","unstructured":"Tudoran C, Tudoran M, Vlad M, Balas M, Ciocarlie T, Parv F. Alterations of heart rate variability and turbulence in female patients with hyperthyroidism of various severities. Niger J Clin Pract. 2019, 22:1349-55. 10.4103\/njcp.njcp_61_18","journal-title":"Niger J Clin Pract"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.04.061","article-title":"Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment","volume":"94","author":"Osman F","year":"2004","unstructured":"Osman F, Franklyn JA, Daykin J, Chowdhary S, Holder RL, Sheppard MC, Gammage MD. Heart rate variability and turbulence in hyperthyroidism before, during, and after treatment. Am J Cardiol. 2004, 94:465-9. 10.1016\/j.amjcard.2004.04.061","journal-title":"Am J Cardiol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2013.0043","article-title":"Differences in heart rate profile during exercise among subjects with subclinical thyroid disease","volume":"23","author":"Maor E","year":"2013","unstructured":"Maor E, Kivity S, Kopel E, Segev S, Sidi Y, Goldenberg I, Olchovsky D. Differences in heart rate profile during exercise among subjects with subclinical thyroid disease. Thyroid. 2013, 23:1226-32. 10.1089\/thy.2013.0043","journal-title":"Thyroid"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-018-3922-4","article-title":"Heart rate variability in hyperthyroidism on sub Saharan African patients: a case-control study","volume":"11","author":"Ngassam E","year":"2018","unstructured":"Ngassam E, Azabji-Kenfack M, Tankeu AT, et al.. Heart rate variability in hyperthyroidism on sub Saharan African patients: a case-control study. BMC Res Notes. 2018, 11:814. 10.1186\/s13104-018-3922-4","journal-title":"BMC Res Notes"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.3.8217","article-title":"Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace?","volume":"87","author":"Osman F","year":"2002","unstructured":"Osman F, Gammage MD, Sheppard MC, Franklyn JA. Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace?. J Clin Endocrinol Metab. 2002, 87:963-7. 10.1210\/jcem.87.3.8217","journal-title":"J Clin Endocrinol Metab"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.87.5.1435","article-title":"The thyroid and the heart","volume":"87","author":"Polikar R","year":"1993","unstructured":"Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993, 87:1435-41. 10.1161\/01.cir.87.5.1435","journal-title":"Circulation"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle JV","year":"2001","unstructured":"Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001, 358:861-5. 10.1016\/S0140-6736(01)06067-6","journal-title":"Lancet"},{"key":"ref52","article-title":"Cardiovascular morbidity and mortality in thyroid dysfunction","volume":"30","author":"D\u00f6rr M","year":"2005","unstructured":"D\u00f6rr M, V\u00f6lzke H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol. 2005, 30:199-216.","journal-title":"Minerva Endocrinol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.02.027","article-title":"Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis","volume":"125","author":"Singh S","year":"2008","unstructured":"Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int J Cardiol. 2008, 125:41-8. 10.1016\/j.ijcard.2007.02.027","journal-title":"Int J Cardiol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-12-0015","article-title":"Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies","volume":"167","author":"Yang LB","year":"2012","unstructured":"Yang LB, Jiang DQ, Qi WB, Zhang T, Feng YL, Gao L, Zhao J. Subclinical hyperthyroidism and the risk of cardiovascular events and all-cause mortality: an updated meta-analysis of cohort studies. Eur J Endocrinol. 2012, 167:75-84. 10.1530\/EJE-12-0015","journal-title":"Eur J Endocrinol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0299","article-title":"A critical review and meta-analysis of the association between overt hyperthyroidism and mortality","volume":"165","author":"Brandt F","year":"2011","unstructured":"Brandt F, Green A, Heged\u00fcs L, Brix TH. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol. 2011, 165:491-7. 10.1530\/EJE-11-0299","journal-title":"Eur J Endocrinol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760143854","article-title":"Hyperthyroidism and cardiovascular morbidity and mortality","volume":"12","author":"Osman F","year":"2002","unstructured":"Osman F, Gammage MD, Franklyn JA. Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid. 2002, 12:483-7. 10.1089\/105072502760143854","journal-title":"Thyroid"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-12-18-4787","article-title":"Atrial fibrillation","volume":"48","author":"Verma KP","year":"2019","unstructured":"Verma KP, Wong M. Atrial fibrillation. Aust J Gen Pract. 2019, 48:694-9. 10.31128\/AJGP-12-18-4787","journal-title":"Aust J Gen Pract"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760143863","article-title":"Hyperthyroidism and the management of atrial fibrillation","volume":"12","author":"Shimizu T","year":"2002","unstructured":"Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid. 2002, 12:489-93. 10.1089\/105072502760143863","journal-title":"Thyroid"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"Ibanez B","year":"2018","unstructured":"Ibanez B, James S, Agewall S, et al.. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018, 39:119-77. 10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1500757","article-title":"Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade","volume":"150","author":"Palmieri EA","year":"2004","unstructured":"Palmieri EA, Fazio S, Palmieri V, Lombardi G, Biondi B. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. Eur J Endocrinol. 2004, 150:757-62. 10.1530\/eje.0.1500757","journal-title":"Eur J Endocrinol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.7302","article-title":"Short-term effects of \u03b2-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease","volume":"51","author":"Tagami T","year":"2012","unstructured":"Tagami T, Yambe Y, Tanaka T, et al.. Short-term effects of \u03b2-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease. Intern Med. 2012, 51:2285-90. 10.2169\/internalmedicine.51.7302","journal-title":"Intern Med"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2017.07.004","article-title":"Atrial fibrillation and hyperthyroidism: a literature review","volume":"69","author":"Reddy V","year":"2017","unstructured":"Reddy V, Taha W, Kundumadam S, Khan M. Atrial fibrillation and hyperthyroidism: a literature review. Indian Heart J. 2017, 69:545-50. 10.1016\/j.ihj.2017.07.004","journal-title":"Indian Heart J"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(91)90707-r","article-title":"Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter","volume":"68","author":"Van Gelder IC","year":"1991","unstructured":"Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991, 68:41-6. 10.1016\/0002-9149(91)90707-r","journal-title":"Am J Cardiol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90850-6","article-title":"Management of atrial fibrillation in the post-thyrotoxic state","volume":"72","author":"Nakazawa HK","year":"1982","unstructured":"Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med. 1982, 72:903-6. 10.1016\/0002-9343(82)90850-6","journal-title":"Am J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s10840-007-9088-y","article-title":"Catheter ablation of atrial fibrillation in patients with hyperthyroidism","volume":"18","author":"Ma CS","year":"2007","unstructured":"Ma CS, Liu X, Hu FL, et al.. Catheter ablation of atrial fibrillation in patients with hyperthyroidism. J Interv Card Electrophysiol. 2007, 18:137-42. 10.1007\/s10840-007-9088-y","journal-title":"J Interv Card Electrophysiol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-12-0340","article-title":"Prevalence and influence of hyperthyroidism on the long-term outcome of catheter ablation for drug-refractory atrial fibrillation","volume":"76","author":"Machino T","year":"2012","unstructured":"Machino T, Tada H, Sekiguchi Y, et al.. Prevalence and influence of hyperthyroidism on the long-term outcome of catheter ablation for drug-refractory atrial fibrillation. Circ J. 2012, 76:2546-51. 10.1253\/circj.cj-12-0340","journal-title":"Circ J"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(89)90642-x","article-title":"Thyrotoxicosis, atrial fibrillation, and embolism, revisited","volume":"117","author":"Presti CF","year":"1989","unstructured":"Presti CF, Hart RG. Thyrotoxicosis, atrial fibrillation, and embolism, revisited. Am Heart J. 1989, 117:976-7. 10.1016\/0002-8703(89)90642-x","journal-title":"Am Heart J"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/clc.22427","article-title":"Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation","volume":"38","author":"Chan PH","year":"2015","unstructured":"Chan PH, Hai J, Yeung CY, Lip GY, Lam KS, Tse HF, Siu CW. Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation. Clin Cardiol. 2015, 38:476-82. 10.1002\/clc.22427","journal-title":"Clin Cardiol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1177\/0885066613503278","article-title":"Amiodarone-induced thyroid dysfunction","volume":"30","author":"Danzi S","year":"2015","unstructured":"Danzi S, Klein I. Amiodarone-induced thyroid dysfunction. J Intensive Care Med. 2015, 30:179-85. 10.1177\/0885066613503278","journal-title":"J Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/92155-hyperthyroidism-and-the-risk-of-cardiac-arrhythmias-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:11Z","timestamp":1707507971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/92155-hyperthyroidism-and-the-risk-of-cardiac-arrhythmias-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":69,"URL":"https:\/\/doi.org\/10.7759\/cureus.24378","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}